SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend]
SEC Accession No. 0001193125-12-051686
Filing Date
2012-02-10
Accepted
2012-02-10 12:51:59
Documents
1
Filing Date Changed
2012-02-10
Group Members
BAY CITY CAPITAL FUND IV CO-INVESTMENT FUND, L.PBAY CITY CAPITAL FUND IV, L.PBAY CITY CAPITAL FUND V CO-INVESTMENT FUND, L.PBAY CITY CAPITAL FUND V, L.PBAY CITY CAPITAL MANAGEMENT IV LLCBAY CITY CAPITAL MANAGEMENT V LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 3 TO SCHEDULE 13G d296796dsc13ga.htm SC 13G/A 108343
  Complete submission text file 0001193125-12-051686.txt   110236
Mailing Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111
Business Address 750 BATTERY STREET STE 400 SAN FRANCISCO CA 94111 4156763830
BAY CITY CAPITAL LLC (Filed by) CIK: 0001288452 (see all company filings)

IRS No.: 943272448 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130
Business Address 12481 HIGH BLUFF DRIVE SUITE 200 SAN DIEGO CA 92130 8584361400
CADENCE PHARMACEUTICALS INC (Subject) CIK: 0001333248 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-82506 | Film No.: 12590999
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1